Comparison of Two Botulinum Toxins Type A on Forehead Wrinkles
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
Single-centre, controlled, randomized, evaluator-blinded, bilateral (split-face) comparison
study in subjects with moderate to severe forehead wrinkles.
One botulinum toxin type A will be injected in one side of the forehead and the other one
will be injected in the other side of the forehead at baseline. Allocation of each BoNT-A to
each side of the forehead will be randomized.
Phase:
Phase 2
Details
Lead Sponsor:
Galderma Galderma R&D
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA